维普期刊资源整合服务平台（V6.5）

93篇 您的检索式：作者名="Elit L"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Intraperitoneal chemotherapy in the first-line treatment of women with stage Ⅲ epithelial ovarian cancer: a systematic review with metaanalyses显示文摘	Elit L Oliver TK Covens A	2007	Cancer2007，109，4：	1
2	Cervical cancer in the older woman显示文摘	Elit L	2014	Maturitas2014，78，3：	1
3	A phase II study of temsirolimus (CCI-779) in patients with metastatic and/or locally advanced recurrent endometrial cancer previously treated with chemotherapy 显示文摘	Oza A Elit L Provencher D	2008	J Clin Oncol2008，26，15：	1
4	Intraperitoneal chemotherapy in the first-line treatment of women with stage Ⅲ epithelial ovarian cancer:a systematic review with metaanalyses显示文摘	Elit L Oliver TK Covens A	2007	Cancer2007，109，：	1
5	Phase II study of erlotinib inrecurrent or metastatic endometrial cancer: NCIC IND-148 显示文摘	Oza A M Eisenhauer E A Elit L	2008	J Clin Oncol2008，26，26：	1
6	Assessment of 2 cervical screening methods in Mongolia: cervical cytology and visual inspection with acetic acid显示文摘	Elit L Baigal G Tan J	2006	J Low Genit Tract Dis2006，10，2：	1
7	CA125 response as a marker of clinical benefit in patients with recurrent ovarian cancer treated with gemcitabine and sorafenib-a trial of the PMH phase II consortium显示文摘	Welch S Hirte H Elit L		0，，18：	1
8	Follow-up after primary therapy for endometrial cancer: a systematic review 显示文摘	Fung-Kee-Fung M Dodge J Elit L	2006	Gynecol Oncol2006，101，：	1
9	Phase ]/ study of temsirolimus in women with recurrent or metastatic endometrial cancer : a trial of the NCIC Clinical Trials Group显示文摘	Oza AM Elit L Tsao MS	2011	J Clin Oncol2011，29，24：	1
10	Women's perceptions about treatment decision making for ovarian cancer显示文摘	L Elit C Charles I Gold	2003	Gynecologic Oncology2003，88，：	1
11	Role of cervical screening in older women显示文摘	Elit L	2014	Maturitas2014，79，4：	1
12	Follow-up after pri- mary therapy for endometrial cancer: a systematic review 显示文摘	Fung-Kee-Fung M Dodge J Elit L	2006	Gynecol Oncol2006，101，：	1
13	Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study显示文摘	Akhtar-Danesh N Elit L Lytwyn A	2014	Gynecol Oncol2014，134，2：	1
14	Phase Ⅱ study of temsirolimus in women with recurrent or metastatic endometrial cancer:a trim of the NCIC Clinical Trials Group显示文摘	Oza AM Elit L Tsao MS		0，，24：	1
15	Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations 显示文摘	Elites M J Urry L A Hemler M E	1991	Cell Biol1991，112，1：	1
16	Phase II study of erlotinib(OSI 774)in women with recurrent or metastatic endometrial cancer:NCIC CTG IND-148显示文摘	Jasas KV Fyles A Elit L		0，，14：	1
17	PhaseⅡstudy of temsirolimus in women with recurrent or metastatic endometrial cancer:a trial of the NCIC Clinical Trials Group显示文摘	Oza AM Elit L Tsao MS	2011	J Clin Oncol2011，29，24：	1
18	Optimal chemothera- py treatment for women with recurrent ovarian cancer 显示文摘	Fung-Kee-Fung M Oliver T Elit L	2007	Curt Onco12007，14，5：	1
19	Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?显示文摘	Goshen R Chu W Elit L	2000	Gynecol Oncol2000，79，3：	1
20	Optimal chemotherapy treatment for women with recurrent ovarian cancer显示文摘	Fung-Kee-Fung M Oliver T Elit L		0，，05：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示